CONDENSED CONSOLIDATED STATEMENTS OPERATIONS AND COMPREHENSIVE INCOME (LOSS) (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Revenue
Total revenue	$ 46,804	$ 44,843
Cost of revenue
Cost of revenue	13,367	13,877
Selling, general, and administrative	23,010	23,085
Income from operations	10,427	7,881
Other income (expense) net :
Interest expense, net	(1,660)	(1,646)
Loss from change in fair value of warrant liability		(1,618)
Loss from change in fair value of earnout liability	(12,089)	(25,410)
Other income (expense)	(2)	(7)
Total other income (expense), net	(13,751)	(28,681)
Loss before provision for income taxes	(3,324)	(20,800)
Income tax expense	2,486	630
Net loss	(5,810)	(21,430)
Less: Net loss attributable to noncontrolling interest	(3,740)	(14,625)
Net loss attributable to biote Corp. stockholders	(2,070)	(6,805)
Other comprehensive income (loss):
Foreign currency translation adjustments	(1)
Other comprehensive income (loss)	(1)
Comprehensive income (loss)	$ (5,811)	$ (21,430)
Net loss per common share
Basic	$ (0.06)	$ (0.39)
Diluted	$ (0.06)	$ (0.39)
Weighted average common shares outstanding
Basic	34,621,166	17,585,045
Diluted	34,621,166	17,585,045
Product Revenue
Revenue
Total revenue	$ 46,035	$ 44,155
Cost of revenue
Cost of revenue	12,802	13,027
Service Revenue
Revenue
Total revenue	769	688
Cost of revenue
Cost of revenue	$ 565	$ 850